Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1989 Mar;82(3):153–158. doi: 10.1177/014107688908200313

Autoimmunity in Graves' ophthalmopathy: a review.

A P Weetman 1
PMCID: PMC1292041  PMID: 2649675

Full text

PDF
153

Images in this article

154Figure 1.
on p.154

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmann A., Baker J. R., Jr, Weetman A. P., Wartofsky L., Nutman T. B., Burman K. D. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metab. 1987 Mar;64(3):454–460. doi: 10.1210/jcem-64-3-454. [DOI] [PubMed] [Google Scholar]
  2. Allannic H., Fauchet R., Lorcy Y., Heim J., Gueguen M., Leguerrier A. M., Genetet B. HLA and Graves' disease: an association with HLA-DRw3. J Clin Endocrinol Metab. 1980 Oct;51(4):863–867. doi: 10.1210/jcem-51-4-863. [DOI] [PubMed] [Google Scholar]
  3. Allen C., Stetz D., Roman S. H., Podos S., Som P., Davies T. F. Prevalence and clinical associations of intraocular pressure changes in Graves' disease. J Clin Endocrinol Metab. 1985 Jul;61(1):183–187. doi: 10.1210/jcem-61-1-183. [DOI] [PubMed] [Google Scholar]
  4. Amino N., Yuasa T., Yabu Y., Miyai K., Kumahara Y. Exophthalmos in autoimmune thyroid disease. J Clin Endocrinol Metab. 1980 Dec;51(6):1232–1234. doi: 10.1210/jcem-51-6-1232. [DOI] [PubMed] [Google Scholar]
  5. Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet. 1984 Aug 18;2(8399):374–376. doi: 10.1016/s0140-6736(84)90543-9. [DOI] [PubMed] [Google Scholar]
  6. Bahn R. S., Gorman C. A., Woloschak G. E., David C. S., Johnson P. M., Johnson C. M. Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. J Clin Endocrinol Metab. 1987 Oct;65(4):665–670. doi: 10.1210/jcem-65-4-665. [DOI] [PubMed] [Google Scholar]
  7. Bech K., Lumholtz B., Nerup J., Thomsen M., Platz P., Ryder L. P., Svejgaard A., Siersbaek-Nielsen K., Hansen J. M., Larsen J. H. HLA antigens in Graves' disease. Acta Endocrinol (Copenh) 1977 Nov;86(3):510–516. doi: 10.1530/acta.0.0860510. [DOI] [PubMed] [Google Scholar]
  8. Blau H. M., Kaplan I., Tao T. W., Kriss J. P. Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci. 1983 Jan 3;32(1-2):45–53. doi: 10.1016/0024-3205(83)90172-8. [DOI] [PubMed] [Google Scholar]
  9. Daicker B. Das gewebliche Substrat der verdickten äussberen Augenmuskeln bei der endokrinen Orbitopathie. Klin Monbl Augenheilkd. 1979 Jun;174(6):843–847. [PubMed] [Google Scholar]
  10. Enzmann D. R., Donaldson S. S., Kriss J. P. Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr. 1979 Dec;3(6):815–819. [PubMed] [Google Scholar]
  11. Farid N. R., Stone E., Johnson G. Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf) 1980 Dec;13(6):535–544. doi: 10.1111/j.1365-2265.1980.tb03421.x. [DOI] [PubMed] [Google Scholar]
  12. Faryna M., Nauman J., Gardas A. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy. Br Med J (Clin Res Ed) 1985 Jan 19;290(6463):191–192. doi: 10.1136/bmj.290.6463.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Frecker M., Stenszky V., Balazs C., Kozma L., Kraszits E., Farid N. R. Genetic factors in Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1986 Nov;25(5):479–485. doi: 10.1111/j.1365-2265.1986.tb03599.x. [DOI] [PubMed] [Google Scholar]
  14. Gamblin G. T., Harper D. G., Galentine P., Buck D. R., Chernow B., Eil C. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy. N Engl J Med. 1983 Feb 24;308(8):420–424. doi: 10.1056/NEJM198302243080803. [DOI] [PubMed] [Google Scholar]
  15. Gwinup G., Elias A. N., Ascher M. S. Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA. 1982 Apr 16;247(15):2135–2138. [PubMed] [Google Scholar]
  16. Henderson J., Wall J. R. Failure of haemagglutination and immunofluorescence methods to detect serum orbital antibodies in patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1981 Feb;14(2):153–158. doi: 10.1111/j.1365-2265.1981.tb00610.x. [DOI] [PubMed] [Google Scholar]
  17. Hiromatsu Y., Fukazawa H., How J., Wall J. R. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells. Clin Exp Immunol. 1987 Dec;70(3):593–603. [PMC free article] [PubMed] [Google Scholar]
  18. Hägg E., Asplund K. Is endocrine ophthalmopathy related to smoking? Br Med J (Clin Res Ed) 1987 Sep 12;295(6599):634–635. doi: 10.1136/bmj.295.6599.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jacobson D. H., Gorman C. A. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr Rev. 1984 Spring;5(2):200–220. doi: 10.1210/edrv-5-2-200. [DOI] [PubMed] [Google Scholar]
  20. Kadlubowski M., Irvine W. J., Rowland A. C. Anti-muscle antibodies in Graves' ophthalmopathy. J Clin Lab Immunol. 1987 Nov;24(3):105–111. [PubMed] [Google Scholar]
  21. Kadlubowski M., Irvine W. J., Rowland A. C. The lack of specificity of ophthalmic immunoglobulins in Graves' disease. J Clin Endocrinol Metab. 1986 Oct;63(4):990–995. doi: 10.1210/jcem-63-4-990. [DOI] [PubMed] [Google Scholar]
  22. Kendall-Taylor P., Atkinson S., Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J (Clin Res Ed) 1984 Apr 21;288(6425):1183–1186. doi: 10.1136/bmj.288.6425.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kendall-Taylor P., Jones D., Atkinson S. The specificity of autoantibodies in Graves' ophthalmopathy. Acta Endocrinol Suppl (Copenh) 1987;281:330–333. doi: 10.1530/acta.0.114s330. [DOI] [PubMed] [Google Scholar]
  24. Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J. R. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet. 1982 Dec 18;2(8312):1353–1356. doi: 10.1016/s0140-6736(82)91267-3. [DOI] [PubMed] [Google Scholar]
  25. Kodama K., Sikorska H., Bayly R., Bandy-Dafoe P., Wall J. R. Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy. J Clin Endocrinol Metab. 1984 Jul;59(1):67–73. doi: 10.1210/jcem-59-1-67. [DOI] [PubMed] [Google Scholar]
  26. Konishi J., Herman M. M., Kriss J. P. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology. 1974 Aug;95(2):434–446. doi: 10.1210/endo-95-2-434. [DOI] [PubMed] [Google Scholar]
  27. Kuroki T., Ruf J., Whelan L., Miller A., Wall J. R. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders. Clin Exp Immunol. 1985 Nov;62(2):361–370. [PMC free article] [PubMed] [Google Scholar]
  28. Ludgate M., Swillens S., Mercken L., Vassart G. Homology between thyroglobulin and acetylcholinesterase: an explanation for pathogenesis of Graves' ophthalmopathy? Lancet. 1986 Jul 26;2(8500):219–220. doi: 10.1016/s0140-6736(86)92515-8. [DOI] [PubMed] [Google Scholar]
  29. Mashieu P., Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab. 1972 Jun;34(6):1090–1092. doi: 10.1210/jcem-34-6-1090. [DOI] [PubMed] [Google Scholar]
  30. Mauri L., Meienberg O., Roth E., König M. P. Evaluation of endocrine ophthalmopathy with saccadic eye movements. J Neurol. 1984;231(4):182–187. doi: 10.1007/BF00313935. [DOI] [PubMed] [Google Scholar]
  31. Melis G. B., Mais V., Paoletti A. M., Beneventi F., Petacchi F. D., Fioretti P. Involvement of endogenous gabaergic system in the modulation of gonadotropin secretion in normal cycling women. J Endocrinol Invest. 1986 Feb;9(1):71–76. doi: 10.1007/BF03348068. [DOI] [PubMed] [Google Scholar]
  32. Mengistu M., Laryea E., Miller A., Wall J. R. Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence. Clin Exp Immunol. 1986 Jul;65(1):19–27. [PMC free article] [PubMed] [Google Scholar]
  33. Mullin B. R., Levinson R. E., Friedman A., Henson D. E., Winand R. J., Kohn L. D. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology. 1977 Feb;100(2):351–366. doi: 10.1210/endo-100-2-351. [DOI] [PubMed] [Google Scholar]
  34. Munro R. E., Lamki L., Row V. V., Volpé R. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab. 1973 Aug;37(2):286–292. doi: 10.1210/jcem-37-2-286. [DOI] [PubMed] [Google Scholar]
  35. Ramsay I. D. Muscle dysfunction in hyperthyroidism. Lancet. 1966 Oct 29;2(7470):931–934. doi: 10.1016/s0140-6736(66)90536-8. [DOI] [PubMed] [Google Scholar]
  36. Roberts A. B., Anzano M. A., Wakefield L. M., Roche N. S., Stern D. F., Sporn M. B. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A. 1985 Jan;82(1):119–123. doi: 10.1073/pnas.82.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rotella C. M., Zonefrati R., Toccafondi R., Valente W. A., Kohn L. D. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab. 1986 Feb;62(2):357–367. doi: 10.1210/jcem-62-2-357. [DOI] [PubMed] [Google Scholar]
  38. Schleusener H., Schernthaner G., Mayr W. R., Kotulla P., Bogner U., Finke R., Meinhold H., Koppenhagen K., Wenzel K. W. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. J Clin Endocrinol Metab. 1983 Apr;56(4):781–785. doi: 10.1210/jcem-56-4-781. [DOI] [PubMed] [Google Scholar]
  39. Schumacher M., Camp S., Maulet Y., Newton M., MacPhee-Quigley K., Taylor S. S., Friedmann T., Taylor P. Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. 1986 Jan 30-Feb 5Nature. 319(6052):407–409. doi: 10.1038/319407a0. [DOI] [PubMed] [Google Scholar]
  40. Sergott R. C., Felberg N. T., Savino P. J., Blizzard J. J., Schatz N. J., Sanford C. A. Association of HLA antigen BW35 with severe Graves' ophthalmopathy. Invest Ophthalmol Vis Sci. 1983 Jan;24(1):124–127. [PubMed] [Google Scholar]
  41. Sikorska H., Wall J. R. Failure to detect eye muscle membrane specific autoantibodies in Graves' ophthalmopathy. Br Med J (Clin Res Ed) 1985 Aug 31;291(6495):604–604. doi: 10.1136/bmj.291.6495.604-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sisson J. C., Vanderburg J. A. Lymphocyte-retrobulbar fibroblast interaction: mechanisms by which stimulation occurs and inhibition of stimulation. Invest Ophthalmol. 1972 Jan;11(1):15–20. [PubMed] [Google Scholar]
  43. Sridama V., Hara Y., Fauchet R., DeGroot L. J. HLA immunogenetic heterogeneity in black American patients with Graves' disease. Arch Intern Med. 1987 Feb;147(2):229–231. [PubMed] [Google Scholar]
  44. Tao T. W., Cheng P. J., Pham H., Leu S. L., Kriss J. P. Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab. 1986 Sep;63(3):577–582. doi: 10.1210/jcem-63-3-577. [DOI] [PubMed] [Google Scholar]
  45. Teng C. S., Smith B. R., Clayton B., Evered D. C., Clark F., Hall R. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease. Clin Endocrinol (Oxf) 1977 Mar;6(3):207–211. doi: 10.1111/j.1365-2265.1977.tb03316.x. [DOI] [PubMed] [Google Scholar]
  46. Teng C. S., Yeo P. P. Ophthalmic Graves's disease: natural history and detailed thyroid function studies. Br Med J. 1977 Jan 29;1(6056):273–275. doi: 10.1136/bmj.1.6056.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Trokel S. L., Jakobiec F. A. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology. 1981 Jun;88(6):553–564. doi: 10.1016/s0161-6420(81)34993-8. [DOI] [PubMed] [Google Scholar]
  48. Wall J. R., Strakosch C. R., Fang S. L., Ingbar S. H., Braverman L. E. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide. Clin Endocrinol (Oxf) 1979 Jan;10(1):79–91. doi: 10.1111/j.1365-2265.1979.tb03036.x. [DOI] [PubMed] [Google Scholar]
  49. Wall J. R., Trewin A., Fang S. L., Ingbar S. H., Braverman L. E. Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease. J Endocrinol Invest. 1978 Jul;1(3):253–258. doi: 10.1007/BF03350389. [DOI] [PubMed] [Google Scholar]
  50. Wall J. R., Walters B. A., Grant C. Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy. J Endocrinol Invest. 1979 Oct-Dec;2(4):375–378. doi: 10.1007/BF03349336. [DOI] [PubMed] [Google Scholar]
  51. Wang P. W., Hiromatsu Y., Laryea E., Wosu L., How J., Wall J. R. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy. J Clin Endocrinol Metab. 1986 Aug;63(2):316–322. doi: 10.1210/jcem-63-2-316. [DOI] [PubMed] [Google Scholar]
  52. Weetman A. P., McGregor A. M. Autoimmune thyroid disease: developments in our understanding. Endocr Rev. 1984 Spring;5(2):309–355. doi: 10.1210/edrv-5-2-309. [DOI] [PubMed] [Google Scholar]
  53. Weetman A. P., So A. K., Warner C. A., Foroni L., Fells P., Shine B. Immunogenetics of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1988 Jun;28(6):619–628. doi: 10.1111/j.1365-2265.1988.tb03853.x. [DOI] [PubMed] [Google Scholar]
  54. Weetman A. P., Tse C. K., Randall W. R., Tsim K. W., Barnard E. A. Acetylcholinesterase antibodies and thyroid autoimmunity. Clin Exp Immunol. 1988 Jan;71(1):96–99. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES